Furthermore, polymorphisms of specific gene encoding angiotensinogen are more frequent in patients with NASH than in control individuals, and angiotensin II type 1 receptor polymorphisms is associated with the occurrence of NASH (5, 37). The gene discussed is AGTR1; the disease is metabolic dysfunction-associated steatohepatitis.